MTOR and Alzheimer disease: Both COX-2 and mTOR have been extensively studied individually and in combination with other speculated regulators of AD in the disease’s progression (Hoozemans et al., 2008; Pei and Hugon, 2008; Tang et al., 2015; Thomas et al., 2016; Mueed et al., 2019).